(Q45036079)

8 December 2017

title

In vivo selection of genetically modified erythroid cells using a jak2-based cell growth switch (English)

1 reference

8 December 2017

1 reference

1 reference

1 reference

Shengming Zhao

1

1 reference

8 December 2017

Michael A Weinreich

2

1 reference

8 December 2017

Kenji Ihara

3

1 reference

8 December 2017

Robert E Richard

4

1 reference

8 December 2017

C Anthony Blau

5

1 reference

8 December 2017

publication date

1 September 2004

1 reference

8 December 2017

1 reference

8 December 2017

volume

10

1 reference

8 December 2017

issue

3

1 reference

8 December 2017

page(s)

456-468

1 reference

Controlling Signal Transduction with Synthetic Ligands

8 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Pharmacologically regulated cell therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

A proliferation switch for genetically modified cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Targeted expansion of genetically modified bone marrow cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Receptor specificity in the self-renewal and differentiation of primary multipotential hemopoietic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Small-molecule-directed mpl signaling can complement growth factors to selectively expand genetically modified cord blood cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

In vivo selection using a cell-growth switch

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Modulating erythrocyte chimerism in a mouse model of pyruvate kinase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Pharmacologically regulated in vivo selection in a large animal

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

The c-Mpl ligand (thrombopoietin) stimulates tyrosine phosphorylation of Jak2, Shc, and c-Mpl

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Structure of the murine Jak2 protein-tyrosine kinase and its role in interleukin 3 signal transduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

JAK2 associates with the beta c chain of the receptor for granulocyte-macrophage colony-stimulating factor, and its activation requires the membrane-proximal region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

IL-5 receptor-mediated tyrosine phosphorylation of SH2/SH3-containing proteins and activation of Bruton's tyrosine and Janus 2 kinases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Activation of JAK2 tyrosine kinase by prolactin receptors in Nb2 cells and mouse mammary gland explants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Identification of JAK2 as a growth hormone receptor-associated tyrosine kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Jak2 is essential for signaling through a variety of cytokine receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Jak2 deficiency defines an essential developmental checkpoint in definitive hematopoiesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Membrane localization is not required for Mpl function in normal hematopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

JAK2, complemented by a second signal from c-kit or flt-3, triggers extensive self-renewal of primary multipotential hemopoietic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Fluorescent proteins from nonbioluminescent Anthozoa species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Granulocytosis causing sickle-cell crisis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Fatal sickle cell crisis after granulocyte colony-stimulating factor administration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Granulocyte colony-stimulating factor-induced sickle cell crisis and multiorgan dysfunction in a patient with compound heterozygous sickle cell/beta+ thalassemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Gene therapy of apolipoprotein E-deficient mice using a novel macrophage-specific retroviral vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

High-level erythroid-specific gene expression in primary human and murine hematopoietic cells with self-inactivating lentiviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Stat5 is essential for the myelo- and lymphoproliferative disease induced by TEL/JAK2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

New perspectives on a developmental dilemma: the kinetic signaling model and the importance of signal duration for the CD4/CD8 lineage decision

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Control of T cell function by positive and negative regulators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

The SOCS box of SOCS-1 accelerates ubiquitin-dependent proteolysis of TEL-JAK2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Socs-1 inhibits TEL-JAK2-mediated transformation of hematopoietic cells through inhibition of JAK2 kinase activity and induction of proteasome-mediated degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

Control of thrombopoietin-induced megakaryocytic differentiation by the mitogen-activated protein kinase pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

A Fas-based suicide switch in human T cells for the treatment of graft-versus-host disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2004.05.014

10.1016/J.YMTHE.2004.05.014

7 January 2021

Identifiers

DOI

1 reference

8 December 2017

1 reference